| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $41.95B | +2.2% |
| R&D Expense | $1.10B | +0.0% |
| SG&A Expense | $4.03B | +1.0% |
| Operating Income | $4.51B | +3.2% |
| Interest Expense | $665.0M | +7.1% |
| Pre-tax Income | $5.07B | +1.0% |
| Income Tax | $886.0M | +5.2% |
| Net Income | $4.18B | +0.2% |
| EPS (Basic) | $29.14 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.40B | +1.1% |
| Accounts Receivable | $1.38B | +8.1% |
| Inventory | $1.31B | -10.0% |
| Current Assets | $15.29B | +7.1% |
| Total Assets | $51.38B | +4.1% |
| Current Liabilities | $13.88B | -1.7% |
| Long-term Debt | $15.70B | -3.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.76B | +8.4% |
| Capital Expenditures | $1.45B | -17.9% |
| Investing Cash Flow | -$1.16B | +34.0% |
| Financing Cash Flow | -$3.55B | -154.6% |
| Free Cash Flow | $3.31B | +26.2% |
| +2.6% |
| EPS (Diluted) | $29.08 | +2.6% |
| Total Liabilities |
| $34.70B |
| +1.9% |
| Stockholders' Equity | $16.67B | +9.1% |